JANICE DRISKELL: Open Payments
NPI 1649756271 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 48 payments from 10 companies in 2025. Trend: 2023 $1,450 · 2024 $1,317 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $383 |
| Amgen Inc. | 15 | $194 |
| Janssen Biotech, Inc. | 4 | $70 |
| PFIZER INC. | 2 | $54 |
| Genentech USA, Inc. | 1 | $30 |
| Aurinia Pharma U.S., Inc. | 1 | $30 |
| Octapharma USA, Inc. | 1 | $25 |
| UCB, Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: SKYRIZI, RINVOQ, EVENITY, TREMFYA, XELJANZ, OTEZLA, Gazyva, LUPKYNIS.
Industry payments across MS — which companies pay providers there.
